Clinical Chemistry Podcast cover art

All Episodes

Clinical Chemistry Podcast — 1000 episodes

#
Title
1

Alpha-Synuclein-Specific RT-QuIC As a Tool for the Differential Diagnosis of Neurodegenerative Diseases Using Peripheral Tissues

2

Predictive Biomarkers for Immune Checkpoint Inhibitor Efficacy: Challenges, Innovations, and a Pathway to Precision Medicine in the Era of Cancer Immunotherapy

3

Tumor-Derived HAVCR1 As a Reliable Fluid Biomarker for the Diagnosis of CNS Lymphoma

4

Audio Summary September 2026

5

Performance, Safety, and Patient Experience of an Autonomous Robotic Phlebotomy Device: A Multicenter Trial

6

Exploring Sex-Specific High-Sensitivity Cardiac Troponin Thresholds for Rule-Out of Non-ST-Elevation Myocardial Infarction

7

Simultaneous Prenatal cfDNA Screening of Aneuploidy, Recessive Single-Gene Conditions, and Fetomaternal Blood Compatibility

8

Audio Summary August 2026

9

From Pooled Cohorts to PREVENT: A Perspective for Clinical Laboratorians

10

Disseminated Coccidioidomycosis in Immunocompetent Hosts: Opportunities for Increased Recognition and Timely Diagnosis

11

Audio Summary July 2026

12

DPYD Sequencing Identifies More Clinically Relevant Variants as Compared to Targeted Genotyping

13

Universal Presence of Gene/Variant Nomenclature Errors in Journal Manuscript Submissions

14

Frameworks of Health Outcomes for Performance Specifications in Laboratory Medicine

15

Fecal Microbiota Therapy: Clinical Laboratory Testing and Metabolomic Approaches for Donor Screening, Product Assessment, and Patient Monitoring

16

Audio Summary June 2026

17

Diagnostic Value of Serum p-tau217 in Alzheimer Disease: Equal to Plasma in Levels and Clinical Utility?

18

Methods to Improve Confidence in the Accuracy of Molecular Testing for Multidrug-Resistant Tuberculosis

19

Audio Summary May 2026

20

Quantum Machine Learning and Data Re-Uploading: Evaluation on Benchmark and Laboratory Medicine Data Sets

21

Scientific Fraud at Scale: Challenges for Trust in Published Data

22

Pre-Exposure Prophylaxis (PrEP)-Associated HIV Monitoring and Self-Testing

23

Endogenous Lithium Levels and Alzheimer Disease

24

Audio Summary April 2026

25

PREEMPT'ing Overreliance on Peripheral Blood-Based ColoRectal Cancer Screening

26

A Turning Point for Lipoprotein(a) Treatment: Are Clinical Laboratories Ready?

27

Audio Summary March 2026

28

Global IVD: Barriers, Trends, and Future

29

Uterus Transplantation—Current Evaluation, Monitoring, and Emerging Diagnostics

30

Audio Summary February 2026

31

Unmet Clinical Needs and Remaining Challenges of Pregnancy Reference Intervals

32

From Diagnosis to Delivery: A Look at the Continuing Gap in Maternal Testing

33

Audio Summary January 2026

34

Per se driving under the influence of cannabis statutes and blood delta-9-tetrahydrocannabinol concentrations following short-term cannabis abstinence

35

Regulatory Fragmentation in Europe and Its Risks for Patient Access and Safety: Subcontracting Work Flow Steps of In-House Diagnostic Procedures

36

Transdermal GFR Signals a New Horizon in Renal Diagnostics

37

Modern Low-Density Lipoprotein Cholesterol Formulas Outperform Direct Methods in Patients with Hypertriglyceridemia and Low Levels of Low-Density Lipoprotein Cholesterol

38

Audio Summary December 2025

39

Post-Translationally Modified Proteoforms as Biomarkers: From Discovery to Clinical Use

40

Embracing Generative Artificial Intelligence as a Support Tool for Clinical Decision-Making

41

Diagnostic Value of Digital Estimates of Trophoblastic Mosaicism in Genome-Wide Cell-Free Fetal DNA Screening

42

Risk vs Prevalence: Weighing Routine DPYD Variant Testing Prior to Fluoropyrimidine-Based Chemotherapy

43

Audio Summary November 2025

44

Optimizing Estimation: Perspective on Drug Dosing Using New CKD-EPI Equations

45

Audio Summary October 2025

46

Utilizing the Stability of Individual Homeostatic Setpoints over Time - A Step Forward on the Path to Personalized Laboratory Medicine

47

Advances in Syphilis Diagnostics to Address the 21st-Century Epidemic

48

Machine Learning for Detecting Iron Deficiency through Comprehensive Blood Analysis

49

Toward Improved Prostate Cancer Screening: Insights from the Göteborg-2 Trial

50

Audio Summary September 2025

51

Proteomic Aging Clock Predicts Mortality and Risk of Common Age-Related Diseases

52

Influence of Macrotroponin on the 99th Percentile Threshold in 2 High-Sensitivity Cardiac Troponin Assays

53

Pulse Oximeter Performance across Populations with Diverse Skin Tones

54

Polygenic Effects on Hb A1c May Mask Hyperglycemia and Increase Retinopathy Risk

55

Audio Summary August 2025

56

Reducing the Noise in Plasma Metagenomics to Further Define Clinical Utility

57

Correlations Within and Between Highly Multiplexed Proteomic Assays of Human Plasma

58

Audio Summary July 2025

59

Robotic Process Automation in Laboratory Medicine

60

HOPEing That a PEACEful Resolution for the Clinical Utility of High-Sensitivity Cardiac Troponin in the Ambulatory Setting Will Improve Laboratory Testing

61

Audio Summary June 2025

62

The Slow Progress in Developing Better Long-Term Cardiovascular Risk Assessment in Women Continues

63

Pediatric vaccine-induced antibody thresholds: Rethinking pre-immunosuppression serologic testing and revaccination implications

64

Reevaluating the threshold for low total testosterone

65

Help Us to Help You: Recommendations for Continued Enforcement Discretion for Common Infectious Disease Test Modifications under the FDA Final Rule

66

Audio Summary May 2025

67

New Clinical Practice Guidelines for Vitamin D Supplementation and Testing

68

Normal Thyroid-Stimulating Hormone and Elevated Free Thyroxine in a Patient Presenting with Self-Reported Heart Palpitations

69

Cardiac Biomarkers and Malnutrition Incidence in Community-Dwelling Older Adults without Cardiovascular Disease: The Seniors-ENRICA-2 Cohort

70

Pharmacogenetic Analysis of CYP2C19 for Clopidogrel: Ready for Prime Time

71

Audio Summary April 2025

72

A Multianalyte Machine Learning Model to Detect Wrong Blood in Complete Blood Count Tube Errors in a Pediatric Setting

73

An AI Model (LORIS) to Predict Immune Checkpoint Blockade Response in Cancer: A Clinical Data Science Perspective

74

Audio Summary March 2025

75

New American Society of Hematology Thrombophilia Guidelines Could Provoke Surge in Laboratory Testing

76

Xylazine Pharmacokinetics in Patients Testing Positive for Fentanyl and Xylazine

77

Rethinking Albuminuria in Low-Risk Patients and a Call for Urine Albumin Standardization

78

Audio Summary February 2025

79

From the Perspective of the Child: Ethical Considerations for the Implementation of Genomic Sequencing into Neonatal and Pediatric Care

80

Overcoming Barriers to Genomic Medicine Implementation

81

Clonality Determination by Detecting Unmodified Monoclonal Serum Free Light Chains Using On-Probe Extraction Coupled with Liquid Chromatography-High-Resolution Mass Spectrometry

82

Audio Summary January 2025

83

Untargeted Metabolomics for Inborn Errors of Metabolism: Development and Evaluation of a Sustainable Reference Material for Correcting Inter-Batch Variability

84

Novel In-Line Hemolysis Detection on a Blood Gas Analyzer and Impact on Whole Blood Potassium Results

85

Forever Chemicals, Endless Testing? Expert Advice to Be Prepared for Per- and Polyfluoroalkyl Substances

86

Audio Summary December 2024

87

Alzheimer disease blood-based biomarkers: Translation from research into clinical use

88

Deconvolution of human urine across the transcriptome and metabolome

89

Niacin and Risk of Cardiovascular Events: Deciphering the Paradox

90

Audio Summary November 2024

91

Approval of the First CRISPR-Cas9 Gene Editing Therapy for Sickle Cell Disease

92

Personalized Reproductive Hormone Monitoring in Sweat

93

Reference Intervals Revisited: A Novel Model for Population-Based Reference Intervals, Using a Small Sample Size and Biological Variation Data

94

Beyond the Screen: Navigating Remote Work within Medicine

95

Audio Summary October 2024

96

ChatGPT vs Medical Professional: Analyzing Responses to Laboratory Medicine Questions on Social Media

97

Congenital Syphilis: An Emerging, Preventable Public Health Crisis

98

The Era of Early Detection and Treatment of Brain Amyloid Deposition in Asymptomatic Individuals?

99

Audio Summary September 2024

100

Clinical Laboratories Confront a New Wave of Drug Overdose Deaths

101

Audio Summary August 2024

102

Osmotic Demyelination Syndrome in Hyponatremia: Does the Rate of Sodium Correction Matter?

103

Breaking Boundaries: Exploring Performance Enhancement and Anti-Doping Testing in Sports

104

Use of Maternal Race and Weight Provides Equitable Performance in Serum Screening for Open Neural Tube Defects

105

Audio Summary July 2024

106

Biological Insights from Cell-Free DNA Methylome Analysis in Preeclampsia

107

Microbiome-Based Diagnostics for Disease: Where Are We Now and Where Are We Headed?

108

Biomarkers vs Machines: The Race to Predict Acute Kidney Injury

109

Audio Summary June 2024

110

Evaluation of Nanopore Sequencing on Polar Bodies for Routine Pre-Implantation Genetic Testing for Aneuploidy

111

Challenges Associated with the Effective Implementation of New Laboratory Tests—The International Experience

112

Time to Reevaluate the 95% Inclusion Criteria for Defining Reference Intervals?

113

Audio Summary May 2024

114

Large Language Models for Scientific Publishing: Please, Do Not Make Them a Foe

115

Eye Catching Advancement for Creutzfeldt–Jakob Disease Diagnostics

116

More Than a Decade of Rapid Genomic Sequencing: Where Are We Now?

117

Audio Summary April 2024

118

Lower Limits for Reporting High-Sensitivity Cardiac Troponin Assays and Impact of Analytical Performance on Patient Misclassification

119

The Next Clinical Decision Frontier: How to Efficiently and Safely Combine Machine Learning and Human Expertise

120

Clinical Decision Support in Laboratory Medicine

121

Audio Summary March 2024

122

New Sepsis Diagnostics and Their Impacts on Clinical Decision-Making and Treatment Protocols

123

Transport of Full-Length Proteins through a Nanopore: One Step Closer to Single-Molecule Proteomics

124

Automating the Detection of IV Fluid Contamination Using Unsupervised Machine Learning

125

Screening in Multiple Myeloma and Its Precursors: Are We There Yet?

126

Eight Misconceptions about Prostate-Specific Antigen

127

Cancer Screening, Incidental Detection, and Overdiagnosis

128

Audio Summary February 2024

129

Reevaluating the Role of High-Density Lipoprotein Cholesterol: New Perspectives on Cardiovascular Disease and Alzheimer Disease

130

Data Analytics in Clinical Laboratories: Advancing Diagnostic Medicine in the Digital Age

131

Audio Summary January 2024

132

Sensitive Blood-Based Detection of HIV-1 and Mycobacterium tuberculosis Peptides for Disease Diagnosis by Immuno-Affinity Liquid Chromatography–Tandem Mass Spectrometry: A Method Development and Proof-of-Concept Study

133

Audio Summary December 2023

134

Early and Accurate Diagnosis of Parkinson Disease May Be Rooted in Seed Amplification Assays

135

AI Chatbots in Clinical Laboratory Medicine: Foundations and Trends

136

Generalizability of a Machine Learning Model for Improving Utilization of Parathyroid Hormone-Related Peptide Testing across Multiple Clinical Centers

137

Audio Summary November 2023

138

Confirmation of Insertion, Deletion, and Deletion-Insertion Variants Detected by Next-Generation Sequencing

139

Generative Artificial Intelligence: More of the Same or Off the Control Chart?

140

Short Timeframe Prediction of Kidney Failure among Patients with Advanced Chronic Kidney Disease

141

Audio Summary October 2023

142

Reference Interval Harmonization: Harnessing the Power of Big Data Analytics to Derive Common Reference Intervals across Populations and Testing Platforms

143

A Machine Learning Model for the Routine Detection of "Wrong Blood in Complete Blood Count Tube" Errors

144

In-Hospital Manufacturing of Cellular Therapies Using Automated Systems

145

Audio Summary September 2023

146

Feasibility of Targeted Next-Generation DNA Sequencing for Expanding Population Newborn Screening

147

Abatacept as a Mimic of Gamma Heavy Chain Disease

148

Assessing the Accuracy and Clinical Utility of ChatGPT in Laboratory Medicine

149

Audio Summary August 2023

150

Machine Learning in Laboratory Medicine: Recommendations of the IFCC Working Group

151

Driving Under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests

152

Tissue Mass Spectrometry: How Solid Is Our Future?

153

Audio Summary July 2023

154

Polygenic Risk Scores: Genomes to Risk Prediction

155

Rapid Rule-Out of Myocardial Infarction Using a Single High-Sensitivity Cardiac Troponin I Measurement Strategy at Presentation to the Emergency Department: The SAFETY Study

156

Using Biomarkers for Traumatic Brain Injury: Are There Lessons That Can Be Learned from Implementing Cardiac Troponin?

157

Audio Summary June 2023

158

The Present and Future of Lipid Testing in Cardiovascular Risk Assessment

159

Multiplexing Homocysteine into First-Tier Newborn Screening Mass Spectrometry Assays Using Selective Thiol Derivatization

160

Lab Medicine in Space

161

Audio Summary May 2023

162

FDA Regulation of Laboratory Clinical Decision Support Software: Is It a Medical Device?

163

The Genotype—Phenotype Conundrum for Antimicrobial Susceptibility Testing

164

Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?

165

Audio Summary April 2023

166

Clinical Perspective on Use of Long-Read Sequencing in Prenatal Diagnosis of Thalassemia

167

Effects of Supplemented Mediterranean Diets on Plasma-Phospholipid Fatty Acid Profiles and Risk of Cardiovascular Disease after 1 Year of Intervention in the PREDIMED Trial

168

A Spotlight on Disruptors and Innovators

169

Audio Summary March 2023

170

Fragment Ends of Circulating Microbial DNA as Signatures for Pathogen Detection in Sepsis

171

Laboratory Preparedness for the Current Monkeypox Outbreak

172

Within-Person and Between-Sensor Variability in Continuous Glucose Monitoring Metrics

173

A Translational Tool to Facilitate Use of Apolipoprotein B for Clinical Decision-Making

174

Audio Summary February 2023

175

Neutral-Coating Capillary Electrophoresis Coupled with High-Resolution Mass Spectrometry for Top-Down Identification of Hemoglobin Variants

176

One Bad Apple Can Spoil the Bunch: The Impact of Contamination in the Clinical Laboratory

177

Can Rapid Nanopore Sequencing Bring Genomic Testing to the Bedside?

178

What is the Importance of Analyzing Tumor Tissues and Blood Cells in the Study of Circulating Tumor-Derived DNA?

179

Audio Summary January 2023

180

Rising to the Challenge: Shortages in Laboratory Medicine

181

Ceramide Risk Scores Can Bring Lipidomics to Clinical Medicine

182

Audio Summary December 2022

183

Identifying Clinically Relevant Bacteria Directly from Culture and Clinical Samples with a Handheld Mass Spectrometry Probe

184

Macrotroponin—Analytical Anomaly or Clinical Confounder

185

The PROVE-HF Study: Additional Proof for the Inclusion of the Manufacturer's Name When Reporting B-Type Natriuretic Peptide Results

186

Clinical Laboratory Informatics and Analytics: Challenges and Opportunities

187

Audio Summary November 2022

188

Cardiac Troponin as a Marker of Heart Failure Risk in Diabetes

189

Estimated Atherosclerotic Cardiovascular Disease Risk Score: An Automated Decision Aid for Statin Therapy

190

Harmonization Status of Serum Ferritin Measurements and Implications for Use as Marker of Iron-Related Disorders

191

Audio Summary October 2022

192

Differences between Educational and Regulatory External Quality Assurance/Proficiency Testing Schemes

193

Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets

194

Rh Blood Group D Antigen Genotyping Using a Portable Nanopore-based Sequencing Device: Proof of Principle

195

Direct-to-Consumer Testing for Routine Purposes

196

Multiplex Fragment Analysis for Flexible Detection of All SARS-CoV-2 Variants of Concern

197

Audio Summary September 2022

198

Reproducibility: Has Cancer Biology Failed beyond Repair?

199

Public Misinformation and Science Communication in Times of Public Health Crises

200

Women in Laboratory Medicine: A Q&A on Diversity and Inclusion

201

Jagged Ends on Multinucleosomal Cell-Free DNA Serve as a Biomarker for Nuclease Activity and Systemic Lupus Erythematosus

202

Critical Roles of Clinical Laboratorians in Translational Research and Applied Sciences—Experts' Insights and Experiences

203

Machine Learning to Assist in Large-Scale, Activity-Based Synthetic Cannabinoid Receptor Agonist Screening of Serum Samples

204

The Need to Develop Clinical Guidance for the Use of High-Sensitivity Cardiac Troponin in Pediatric and Neonatal Patients

205

Audio Summary August 2022

206

Audio Summary July 2022

207

Evaluation of Neutralizing Antibodies against SARS-CoV-2 Variants after Infection and Vaccination Using a Multiplexed Surrogate Virus Neutralization Test

208

Angiogenic Biomarkers for Risk Stratification in Women with Preeclampsia

209

A Novel Approach to Improve Accuracy of CYP2D6 Enzyme Activity and Drug Response Predictions

210

Audio Summary June 2022

211

Toward Clinical Application of Leukocyte Counts Based on Targeted DNA Methylation Analysis

212

How Not to Introduce Laboratory Tests to Clinical Practice: Preimplantation Genetic Testing for Aneuploidy

213

New Equations for Estimating Glomerular Filtration Rate

214

A Paradigm Shift: Engagement of Clinical Chemistry and Laboratory Medicine Trainees by Innovative Teaching Methods

215

Glycated Albumin: Added Value or Redundancy in Diabetes Care?

216

Interpreting EQA—Understanding Why Commutability of Materials Matters

217

How Can We Ensure Reproducibility and Clinical Translation of Machine Learning Applications in Laboratory Medicine?

218

Audio Summary May 2022

219

Pregnancy in the Time of COVID-19: What Are the Challenges for Maternity Care?

220

Audio Summary April 2022

221

Alternative Sample Matrices Supporting Remote Sample Collection during the Pandemic and Beyond

222

Galaxy Is a Suitable Bioinformatics Platform for the Molecular Diagnosis of Human Genetic Disorders Using High-Throughput Sequencing Data Analysis: Five Years of Experience in a Clinical Laboratory

223

Audio Summary March 2022

224

Chest Pain Assessment: What Is Our Endgame?

225

Deadly Pathogens, Transformative Technologies, and Protracted Pandemics: Challenges and Opportunities in Laboratory Medicine

226

At-Home Testing for Infectious Diseases: The Laboratory Where You Live

227

Audio Summary February 2022

228

A Push for Real Normal: Mass Screening for COVID-19

229

Audio Summary January 2022

230

Challenges in Translating Clinical Metabolomics Data Sets from the Bench to the Bedside

231

Digital Microfluidic Hemagglutination Assays for Blood Typing, Donor Compatibility Testing, and Hematocrit Analysis

232

Circulating Ceramides and Sphingomyelins and Risk of Mortality: The Cardiovascular Health Study

233

Molecular Approaches to Transplant Monitoring; Is the Horizon Here?

234

Audio Summary December 2021

235

Liquid Biopsy Hotspot Variant Assays: Analytical Validation for Application in Residual Disease Detection and Treatment Monitoring

236

Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung Cancer

237

The European Biological Variation Study (EuBIVAS): Biological Variation Data for Coagulation Markers Estimated by a Bayesian Model

238

Perspectives on Identifying and Treating Familial Hypercholesterolemia in Childhood

239

Audio Summary November 2021

240

Can High-Sensitivity Troponins Help to Level the Playing Field in Cardiovascular Disease Prevention between Women and Men?

241

TOP-Plus is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody Durability

242

Audio Summary October 2021

243

High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19

244

Cardiac Biomarkers in Pediatrics: An Undervalued Resource

245

Audio Summary September 2021

246

AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 EUA and LDT Serologic Testing in Clinical Laboratories

247

How Well Do Laboratories Adhere to Recommended Guidelines for Cardiac Biomarkers Management in Europe? The CArdiac MARker Guideline Uptake in Europe (CAMARGUE) Study of the European Federation of Laboratory Medicine Task Group on Cardiac Markers

248

Big Data Strikes Again: Future Utilization of the UK Biobank as a Resource for Clinical Laboratories

249

Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV-2 IgG Results

250

Serum Prostate-Specific Antigen Testing for Early Detection of Prostate Cancer: Managing the Gap Between Clinical and Laboratory Practice

251

Audio Summary August 2021

252

Associating SARS-CoV-2 Serological Assays with Protection: Where the Field Stands

253

Laboratory Action Plan for Emerging SARS-CoV-2 Variants

254

Audio Summary July 2021

255

Centralized vs Decentralized Molecular Infectious Disease Testing

256

Is it Time to move on? Reexamining Race in Glomerular Filtration Rate Equations

257

Limitations of Accelerated Stability Model Based on the Arrhenius Equation for Shelf Life Estimation of In Vitro Diagnostic Products

258

Interoperability: COVID-19 as an Impetus for Change.

259

Audio Summary June 2021

260

Audio Summary May 2021

261

Development of an LC-MS/MS Proposed Candidate Reference Method for the Standardization of Analytical Methods to Measure Lipoprotein(a)

262

Clinical Protein Analysis by Mass Spectrometry: A New Higher Order

263

Audio Summary April 2021

264

Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaboration

265

Personalized Reference Intervals in Laboratory Medicine: A New Model Based on Within-Subject Biological Variation

266

The Dynamic and Multifaceted Nature of Cardiovascular Disease and Using Genetic Testing to Inform Clinical Care: An International Perspective

267

Audio Summary March 2021

268

The Vitamin D Metabolite Ratio is Independent of Vitamin D Binding Protein Concentration

269

Audio Summary February 2021

270

Nonfasting Lipid Profile for all Patients?

271

B-Type Natriuretic Peptide Is Associated with Favorable Left Ventricular Function in General Population

272

Audio Summary January 2021

273

Deus ex machina? Predicting SARS-CoV-2 Infection from Lab Tests Using Machine Learning.

274

SARS-CoV-2 Whole Genome Amplification and Sequencing for Effective Population-Based Surveillance and Control of Viral Transmission

275

Cautionary Note on Contamination of Reagents Used for Molecular Detection of SARS-CoV-2

276

Genomic Prediction of Antimicrobial Resistance: Ready or Not, Here It Comes!

277

The Faces of Women in AACC - A Historical Reflection on AACC Leadership and Awards

278

Audio Summary December 2020

279

Cell-free DNA fragmentomics: the new "omics" on the block

280

Audio Summary November 2020

281

Examining Laboratory Medicine's Role in Eliminating Health Disparities

282

Proportion of Donor Specific Cell-Free DNA in Blood as a Marker of Transplant Rejection: Not an Absolute

283

Patient-Based Real Time QC

284

Evaluation of the Risk of Laboratory Microbial Contamination During Routine Testing in Automated Clinical Chemistry and Microbiology Laboratories

285

Audio Summary October 2020

286

In-Depth Analysis of Molecular Heterogeneity of Circulating N-Terminal pro-BNP: Does Detailed Characterization of Analyte Structure Really Matter for its Diagnostic Use?

287

Throughput Considerations for a Sample-Multiplexed LC-MS/MS Assay: Is the Ability to Double the Injection Throughput Always a Time Saver?

288

Recognition of the Pre-hospital Preanalytical Phase: Collaborative Efforts between Laboratory Medicine and Emergency Medicine to Ensure Quality Testing

289

Clinical Performance of Two SARS-CoV-2 Serologic Assays

290

Audio Summary September 2020

291

Machine Learning for the Biochemical Genetics Laboratory

292

Audio Summary August 2020

293

IFCC Working Group Recommendations for Correction of Bias Caused by Noncommutability of a Certified Reference Material Used in the Calibration Hierarchy of an End-User Measurement Procedure

294

Fecal Microbiota Transplantations: Where Are We, Where Are We Going, and What Is the Role of the Clinical Laboratory?

295

Modification of In Vitro Diagnostic Devices: Leveling the Playing Field

296

Audio Summary July 2020

297

July 2020 Summary Peddu

298

July 2020 Summary Caswell

299

July 2020 Summary Pitella-Silva

300

July 2020 Summary Lau

301

July 2020 Summary Jensen

302

July 2020 Summary McGrath

303

June 2020 Summary Benoist

304

June 2020 Summary Min

305

June 2020 Summary Crawford

306

June 2020 Summary Tafess

307

June 2020 Summary Trouillet-Assant

308

June 2020 Summary Pan

309

Audio Summary June 2020

310

SARS-CoV-2 Serology: Much Hype, Little Data

311

Development, Validation, and Regulatory Considerations for a Liquid Biopsy Test

312

Audio Summary May 2020

313

May 2020 Summary Clouet-Foraison

314

May 2020 Summary Liu

315

May 2020 Summary Guo

316

May 2020 Summary Heider

317

May 2020 Summary Hicks

318

May 2020 Summary Colak

319

Calibrating from Within: Multipoint Internal Calibration of a Quantitative Mass Spectrometric Assay of Serum Methotrexate

320

Audio Summary April 2020

321

April 2020 Summary Silveira

322

April 2020 Summary Lam

323

April 2020 Summary Korecka

324

April 2020 Summary Moncrieffe

325

April 2020 Summary Lyngbakken

326

April 2020 Summary Jongejan

327

April 2020 Summary Chu

328

Mass Spectrometry for Identification, Monitoring, and Minimal Residual Disease Detection of M-Proteins

329

Clinical Relevance of the 99th Percentile Upper Reference Limit for High-Sensitivity Cardiac Troponin Assays

330

Emergence of a Novel Coronavirus Disease (COVID-19) and the Importance of Diagnostic Testing: Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak [Chinese Translation]

331

Sex-Specific 99th Percentile Upper Reference Limits for High Sensitivity Cardiac Troponin Assays Derived Using a Universal Sample Bank

332

Development and Clinical Validation of a Sensitive Lateral Flow Assay for Rapid Urine Fentanyl Screening in the Emergency Department

333

Emergence of a Novel Coronavirus Disease (COVID-19) and the Importance of Diagnostic Testing: Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak

334

Audio Summary March 2020

335

March 2020 Summary Guo

336

March 2020 Summary Hoffman

337

March 2020 Summary Blesa

338

March 2020 Summary Sun

339

March 2020 Summary Lam

340

March 2020 Summary Apple

341

Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia [Chinese Translation]

342

Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia

343

February 2020 Summary Pruner

344

February 2020 Summary Jin

345

February 2020 Summary Malka

346

February 2020 Summary Vigneron

347

February 2020 Summary Ge

348

February 2020 Summary Starnberg

349

February 2020 Summary Li

350

February 2020 Summary O'Malley

351

Audio Summary February 2020

352

Circulating Tumor DNA for Modern Cancer Management

353

Microbiome Diagnostics

354

Unconventional Diagnosis Based on Somatic Findings through Germ Line Whole-Exome Sequencing

355

Predictive and Precision Medicine with Genomic Data

356

Molecular Diagnostics: Going from Strength to Strength

357

Audio Summary January 2020

358

January 2020 Summary Coelho-Lima

359

January 2020 Summary Wu

360

January 2020 Summary Profaizer

361

January 2020 Summary Zucha

362

January 2020 Summary Chandler

363

January 2020 Summary Gotway

364

January 2020 Summary Ge

365

January 2020 Summary Song

366

January 2020 Summary Lin

367

January 2020 Summary Joosse

368

January 2020 Summary Lampignano

369

Ethics for Laboratory Medicine

370

Laboratory Measurement's Contribution to the Replication and Application Crisis in Clinical Research

371

Audio Summary December 2019

372

December 2019 Summary Sorensen

373

December 2019 Summary Meisterzheim

374

December 2019 Summary Weber

375

December 2019 Summary Salamin

376

December 2019 Summary Sun

377

December 2019 Summary Yang

378

December 2019 Summary Wussler

379

December 2019 Summary Hughey

380

December 2019 Summary Costenbader

381

Circular RNAs as Urinary Biomarkers

382

ProBNP That Is Not Glycosylated at Threonine 71 Is Decreased with Obesity in Patients with Heart Failure

383

An Intact ACTH LC-MS/MS Assay as an Arbiter of Clinically Discordant Immunoassay Results

384

Audio Summary November 2019

385

November 2019 Summary Bansal

386

November 2019 Summary Nestelberger

387

November 2019 Summary Boeddinghaus

388

November 2019 Summary Yang

389

November 2019 Summary O' Leary

390

November 2019 Summary Shi

391

November 2019 Summary van Faassen

392

November 2019 Summary Potter

393

A View on the Interrelationship between Obesity and Natriuretic Peptide Measurements: Can Dysregulation in pro–B-type Natriuretic Peptide Glycosylation Explain Decreased B-type Natriuretic Peptide Concentrations in Obese Heart Failure Patients?

394

Urinary Amino-Terminal Pro–C-Type Natriuretic Peptide: A Novel Marker of Chronic Kidney Disease in Diabetes

395

Role of BNP vs NT-proBNP Testing in the Age of New Drug Therapies: Sacubitril-Valsartan

396

Once-Per-Visit Alerts: A Means to Study Alert Compliance and Reduce Repeat Laboratory Testing

397

Detection of Neprilysin-Derived BNP Fragments in the Circulation: Possible Insights for Targeted Neprilysin Inhibition Therapy for Heart Failure

398

Audio Summary October 2019

399

October 2019 Summary Hoq

400

October 2019 Summary Takahashi

401

October 2019 Summary van Tol

402

October 2019 Summary Kolling

403

October 2019 Summary Sun

404

October 2019 Summary Garrel

405

October 2019 Summary Chan

406

October 2019 Summary Prickett

407

October 2019 Summary Feygina

408

Optimal Use of Biomarkers for Chronic Kidney Disease

409

September 2019 Summary Lynch

410

September 2019 Summary Ma

411

September 2019 Summary Cassinari

412

September 2019 Summary Lampasona

413

September 2019 Summary Lampignano

414

September 2019 Summary Szymanski

415

September 2019 Summary Lewis

416

September 2019 Summary IIkezaki

417

Audio Summary September 2019

418

Patient-Based Real-Time Quality Control: Review and Recommendations

419

The National Glycohemoglobin Standardization Program: Over 20 Years of Improving Hemoglobin A1c Measurement

420

Noninvasive Detection of Bladder Cancer by Shallow-Depth Genome-Wide Bisulfite Sequencing of Urinary Cell-Free DNA for Methylation and Copy Number Profiling

421

Audio Summary August 2019

422

August 2019 Summary Chen

423

August 2019 Summary Kuusisto

424

August 2019 Summary Carobene2

425

August 2019 Summary Hjort

426

August 2019 Summary Sepiashvili

427

August 2019 Summary Body

428

August 2019 Summary Roraas

429

August 2019 Summary He

430

Audio Summary July 2019

431

July 2019 Summary Cheng

432

July 2019 Summary JLi

433

July 2019 Summary Tan

434

July 2019 Summary Boeddinghaus

435

July 2019 Summary Vylegzhanina

436

03 Summary Lyngbakken

437

July 2019 Summary Whitman

438

July 2019 Summary Grammer

439

Low HDL Cholesterol and High Risk of Autoimmune Disease: Two Population-Based Cohort Studies Including 117341 Individuals

440

Inspiring Minds-: Patrick Bossuyt

441

What the Protecting Access to Medicare Act Means for Clinical Laboratories

442

A Message to Medical School Promotion Committees: Proper Credit for Peer-Reviewed Online Educational Materials

443

Generation of Highly Biomimetic Quality Control Materials for Noninvasive Prenatal Testing Based on Enzymatic Digestion of Matched Mother–Child Cell Lines

444

Audio Summary June 2019

445

June 2019 Summary Li

446

June 2019 Summary Burkve

447

June 2019 Summary Zelniker

448

June 2019 Summary Matin

449

June 2019 Summary Zhang

450

June 2019 Summary Mendelian Randomization Group

451

Increased Clinical Sensitivity and Specificity of Plasma Protein N-Glycan Profiling for Diagnosing Congenital Disorders of Glycosylation by Use of Flow Injection–Electrospray Ionization–Quadrupole Time-of-Flight Mass Spectrometry

452

Privacy in Direct-to-Consumer Genetic Testing

453

Parameters for Validating a Hospital Pneumatic Tube System

454

May 2019 Summary Farnsworth

455

May 2019 Summary Hartley

456

May 2019 Summary Sans

457

May 2019 Summary Yu

458

May 2019 Summary Chen

459

May 2019 Summary Madsen

460

Audio Summary May 2019

461

Can Mendelian Randomization Shift into Reverse Gear?

462

Challenges in the Assessment and Diagnosis of Polycystic Ovary Syndrome

463

A Mendelian Randomization-Based Approach to Identify Early and Sensitive Diagnostic Biomarkers of Disease

464

Validation of a Metabolite Panel for a More Accurate Estimation of Glomerular Filtration Rate Using Quantitative LC-MS/MS

465

Which Methods for Determining Glomerular Filtration Rate Most Strongly Associate with Risk of Progression of Kidney Disease?

466

Audio Summary April 2019

467

April 2019 Summary Jones

468

April 2019 Summary Yin

469

April 2019 Summary Jung

470

April 2019 Summary Franken

471

April 2019 Summary Fredsoe

472

April 2019 Summary Norman

473

Inflammatory Biomarkers and Clinical Judgment in the Emergency Diagnosis of Urgent Abdominal Pain

474

Type III Hyperlipoproteinemia: The Forgotten, Disregarded, Neglected, Overlooked, Ignored but Highly Atherogenic, and Highly Treatable Dyslipoproteinemia

475

March 2019 Summary Anand

476

March 2019 Summary Braga

477

March 2019 Summary Riethdorf

478

March 2019 Summary Rackow

479

March 2019 Summary Boeddinghaus

480

March 2019 Summary Mohammadi-Shemirani

481

March 2019 Summary Toes-Zoutendijk

482

March 2019 Summary Freed

483

Audio Summary March 2019

484

Development and Validation of Apolipoprotein AI-Associated Lipoprotein Proteome Panel for the Prediction of Cholesterol Efflux Capacity and Coronary Artery Disease

485

Using Machine Learning to Aid the Interpretation of Urine Steroid Profiles

486

Audio Summary February 2019

487

February 2019 Summary Wood

488

February 2019 Summary Hansen

489

February 2019 Summary Boot

490

February 2019 Summary Breidthardt

491

February 2019 Summary Salameh

492

February 2019 Summary Jin

493

February 2019 Summary Kong

494

February 2019 Summary Myrick

495

Assessment of Digital PCR as a Primary Reference Measurement Procedure to Support Advances in Precision Medicine

496

Differences in Health Outcomes between Men and Women: Biological, Behavioral, and Societal Factors

497

Male Contraceptive Development: Update on Novel Hormonal and Nonhormonal Methods

498

Redesigning Prostate Cancer Screening Strategies to Reduce Overdiagnosis

499

Updates on Screening, Prevention, Treatment, and Genetic Markers for Preeclampsia

500

CRISPR Methods for Nucleic Acid Detection Herald the Future of Molecular Diagnostics

501

Audio Summary January 2019

502

January 2019 Summary Winston-McPherson

503

January 2019 Summary Marrone

504

January 2019 Summary Srinivasan

505

January 2019 Summary Mikkelsen

506

January 2019 Summary SoRelle

507

January 2019 Summary Jayasena

508

Direct Comparison of Cardiac Troponin T and I using a Uniform and a Sex-specific Approach in the Detection of Functionally Relevant Coronary Artery Disease

509

Influence of Molecular Testing on Influenza Diagnosis

510

Decmeber 2018 Summary Huang

511

December 2018 Summary Kiehl

512

December 2018 Summary Folch

513

December 2018 Summary Liu

514

December 2018 Summary Milosevic

515

December 2018 Summary Hejl

516

December 2018 Summary Smith

517

December 2018 Summary Neumann

518

Audio Summary December 2018

519

Audio Summary November 2018

520

November 2018 Summary Parker

521

November 2018 Summary Eisenhofer

522

November 2018 Summary Sharma

523

November 2018 Summary Mansukhani

524

November 2018 Summary Ibrahim

525

November 2018 Summary Welsh

526

November 2018 Summary Mueller

527

November 2018 Summary Wilkes

528

Current and Emerging Trends in Point-of-Care Technology and Strategies for Clinical Validation and Implementation

529

Commutability Assessment of Candidate Reference Materials for Pancreatic α-Amylase

530

October 2018 Summary Zavridou

531

October 2018 Summary Li

532

October 2018 Summary Joosse

533

October 2018 Summary Lee

534

October 2018 Summary Delatour

535

October 2018 Summary Beck

536

October 2018 Summary Kabe

537

October 2018 Summary Andini

538

Audio Summary October 2018

539

September 2018 Summary Wald

540

September 2018 Summary Aarsand

541

September 2018 Summary Myhre

542

September 2018 Summary Caironi

543

September 2018 Summary Boeddinghaus

544

September 2018 Summary Silva

545

September 2018 Summary Guo

546

September 2018 Summary Darebna

547

Audio Summary September 2018

548

Validation of an Expanded Carrier Screen that Optimizes Sensitivity via Full-Exon Sequencing and Panel-wide Copy Number Variant Identification

549

Toward a Global Overview of HbA1c Test Performance

550

Preanalytical Processing and Biobanking Procedures of Biological Samples for Metabolomics Research

551

Association of Tryptophan Metabolites with Incident Type 2 Diabetes in the PREDIMED Trial: A Case–Cohort Study

552

Characterization of Human Salivary Extracellular RNA by Next-generation Sequencing

553

RNA Profiles of Circulating Tumor Cells and Extracellular Vesicles for Therapy Stratification of Metastatic Breast Cancer Patients

554

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

555

Audio Summary August 2018

556

August 2018 Summary Gai

557

August 2018 Summary Kim

558

August 2018 Summary Cannaert

559

August 2018 Summary Yu

560

August 2018 Summary Tobias

561

August 2018 Summary Deprez

562

August 2018 Summary EurA1C Group

563

Full-Size Cardiac Troponin I and Its Proteolytic Fragments in Blood of Patients with Acute Myocardial Infarction: Antibody Selection for Assay Development

564

Audio Summary July 2018

565

July 2018 Summary Rasmussen

566

July 2018 Summary Katrukha

567

July 2018 Summary Alimohamed

568

July 2018 Summary Li

569

July 2018 Summary Ludwig

570

July 2018 Summary Hogan

571

July 2018 Summary Keup

572

July 2018 Summary Than

573

Clinical Utility of Transcriptome Sequencing: Toward a Better Diagnosis for Mendelian Disorders

574

Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study

575

Clinical Evaluation of a Blood Assay to Diagnose Paucibacillary Tuberculosis via Bacterial Antigens

576

Audio Summary June 2018

577

June 2018 Summary Schirmer

578

June 2018 Summary Waalkes

579

June 2018 Summary Wu

580

June 2018 Summary Willemse

581

June 2018 Summary Cannaert

582

June 2018 Summary Ismail

583

Clinical and Genomic Insights from Metastatic Cancers

584

From DESI to the MasSpec Pen: Ambient Ionization Mass Spectrometry for Tissue Analysis and Intrasurgical Cancer Diagnosis

585

Evaluating Rapid Rule-out of Acute Myocardial Infarction Using a High-Sensitivity Cardiac Troponin I Assay at Presentation

586

Audio Summary May 2018

587

May 2018 Summary Hilderink

588

May 2018 Summary Selvin

589

May 2018 Summary Haselmann

590

May 2018 Summary Greenslade

591

May 2018 Summary X Liu

592

May 2018 Summary Rejali

593

May 2018 Summary C Liu

594

Advanced Whole-Genome Sequencing and Analysis of Fetal Genomes from Amniotic Fluid

595

Comparing Measures of HDL: On the Right Path with the Wrong Map

596

The Biological Variation Data Critical Appraisal Checklist: A Standard for Evaluating Studies on Biological Variation

597

Audio Summary April 2018

598

April 2018 Summary vanderGugten

599

April 2018 Summary Kim

600

April 2018 Summary Mao

601

April 2018 Summary Amr

602

April 2018 Summary Topbas

603

April 2018 Summary Masi

604

April 2018 Summary deRond

605

Non-invasive Detection of Cocaine and Heroin Use Using Single Fingerprints

606

Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or Ezetimibe

607

Plasma Steroid Metabolome Profiling for Diagnosis and Subtyping Patients with Cushing Syndrome

608

IFCC Working Group Recommendations for Assessing Commutability

609

Evaluation of Thyroid Function during Pregnancy: Have We Taken a Wrong Turn?

610

March 2018 Summary Badertscher

611

Audio Summary March 2018

612

March 2018 Summary Pavo

613

March 2018 Summary Eisenhofer

614

March 2018 Summary Tijms

615

March 2018 Summary Frobel

616

March 2018 Summary Kim

617

March 2018 Summary Greiner

618

March 2018 Summary El Heliebi

619

March 2018 Summary Zhou

620

March 2018 Summary Aarsand

621

March 2018 Summary Matera

622

Audio Summary February 2018

623

February 2018 Summary Walter

624

February 2018 Summary Moen

625

February 2018 Summary Prickett

626

February 2018 Summary Ruel

627

February 2018 Summary Hill

628

February 2018 Summary Camunas-Soler

629

February 2018 Summary Dharajiya

630

February 2018 Summary Decraene

631

February 2018 Summary Aalipour

632

February 2018 Summary Markou

633

February 2018 Summary Westgard

634

February 2018 Summary Farrokhi

635

Dietary Fat: Friend or Foe?

636

Use of Metabolomics in Improving Assessment of Dietary Intake

637

Bad Breaks and Metabolic Effects of Bariatric Surgery

638

New Therapies for Treating Hepatitis C Virus: Impact on Laboratory Testing Recommendations and Clinical Management

639

High-Resolution, Accurate-Mass (HRAM) Mass Spectrometry Urine Steroid Profiling in the Diagnosis of Adrenal Disorders

640

January 2018 Summary Ahmad

641

January 2018 Summary Varbo

642

January 2018 Summary Castillo

643

January 2018 Summary Ndumele

644

January 2018 Summary Astley

645

January 2018 Summary Mendelian Group

646

Audio Summary January 2018

647

Clinical Case Study: Unusual Cause of Abdominal Pain and Anemia

648

Using Biomarkers to Guide Heart Failure Therapy

649

Audio Summary December 2017

650

December 2017 Summary Silbernagel

651

December 2017 Summary Jagodzinski

652

December 2017 Summary Tolbus

653

December 2017 Summary McCudden

654

December 2017 Summary Durant

655

December 2017 Summary Taylor

656

December 2017 Summary Hines

657

The Role of Procalcitonin in Diagnosis of Sepsis and Antibiotic Stewardship: Opportunities and Challenges

658

Audio Summary November 2017

659

November 2017 Summary Diao

660

November 2017 Summary Costa

661

November 2017 Summary Noceti

662

November 2017 Summary Ferencik

663

November 2017 Summary Langsted

664

November 2017 Summary Cao

665

November 2017 Summary Pan

666

High-Sensitivity Troponin: Star Player but No Lone Hero

667

Implementing a Reference Measurement System for C-Peptide: Successes and Lessons Learned

668

Audio Summary October 2017

669

October 2017 Summary DeGrande

670

October 2017 Summary Gool

671

October 2017 Summary Pryor

672

October 2017 Summary Lam

673

October 2017 Summary Ladas

674

October 2017 Summary Sandoval

675

October 2017 Summary Bredemeier

676

Overinterpretation of Research Findings: Evidence of "Spin" in Systematic Reviews of Diagnostic Accuracy Studies

677

Patient Privacy and Clinical Laboratory Data

678

When Gender Identity Doesn't Equal Sex Recorded at Birth: The Role of the Laboratory in Providing Effective Healthcare to the Transgender Community

679

Audio Summary September2017

680

September 2017 Summary Carobene

681

September 2017 Summary Cardenas-Gonzalez

682

September 2017 Summary Do

683

September 2017 Summary Ebai

684

September 2017 Summary Kahaly

685

September 2017 Audio Summary Kahraman

686

September 2017 Audio Summary Zhang

687

Facilitating Prospective Registration of Diagnostic Accuracy Studies: A STARD Initiative

688

August 2017 Audio Summary

689

August 2017 Audio Summary Eggers

690

August 2017 Audio Summary Wang

691

August 2017 Audio Summary Sillence

692

August 2017 Audio Summary Bietenbeck

693

August 2017 Audio Summary Christenson

694

August 2017 Audio Summary Liao

695

August 2017 Audio Summary McGrath

696

Harmonization: Its Time Has Come

697

Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non–ST-Segment Elevation Acute Coronary Syndrome

698

July 2017 Audio Summary

699

July 2017 Audio Summary Schrock

700

July 2017 Audio Summary Harada

701

July 2017 Audio Summary Liao

702

July 2017 Audio Summary Ong

703

July 2017 Audio Summary Thienpont

704

July 2017 Audio Summary Duprez

705

July 2017 Audio Summary Wildi

706

July 2017 Audio Summary Chan

707

Thrombin-Mediated Degradation of Human Cardiac Troponin T

708

Distinguishing Intake of New Synthetic Cannabinoids ADB-PINACA and 5F-ADB-PINACA with Human Hepatocyte Metabolites and High-Resolution Mass Spectrometry

709

June 2017 Audio Summary

710

June 2017 Audio Summary Kobylecki

711

June 2017 Audio Summary Carobene

712

June 2017 Audio Summary Lian

713

June 2017 Audio Summary Liu

714

June 2017 Audio Summary Lewis

715

June 2017 Audio Summary Dieplinger

716

June 2017 Audio Summary Katrukha

717

Fifty Shades of Yellow

718

May 2017 Audio Summary

719

Association of Blood Eosinophil and Blood Neutrophil Counts with Asthma Exacerbations in the Copenhagen General Population Study

720

FullIssueSummary April2017

721

Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA Repair

722

Are THC Levels in Oral Fluids and Blood Plasma Comparable after Oral Ingestion of Edibles Containing Cannabis or THC?

723

High Glycated Albumin and Mortality in Persons with Diabetes Mellitus on Hemodialysis

724

Bone Turnover Markers in the Diagnosis and Monitoring

725

Clinical Chemistry's Commitment to Education: Stronger than Ever

726

Patient Consent and the Commercialization of Lab Data

727

FullIssueSummary February2017

728

Diurnal Rhythm of Cardiac Troponin: Consequences for the Diagnosis of Acute Myocardial Infarction

729

Universal Haplotype-Based Noninvasive Prenatal Testing for Single Gene Diseases

730

Short-term variability of vitamin D-related biomarkers

731

Early rule-out and rule-in strategies for myocardial infarction

732

Interpreting Cardiac Biomarkers in the Setting of Chronic Kidney Disease

733

Biomarkers for Clinical Decision-Making in the Management of Pulmonary Embolism

734

Immediate Rule-Out of Acute Myocardial Infarction Using Electrocardiogram and Baseline High-Sensitivity Troponin I

735

Myocardial Infarction Type 2 and Myocardial Injury

736

Trimethylamine N-oxide and Risk Stratification after Acute Myocardial Infarction

737

FullIssueSummary January2017

738

Alcohol consumption and cardiac biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study

739

Is the $1,000 genome as near as we think? A cost analysis of next-generation sequencing

740

Optimization of a Moving Averages Program Using a Simulated Annealing Algorithm

741

A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources

742

Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry

743

A Study of Hypermethylated Circulating Tumor

744

What Can a Clinical Chemist Learn from Aviation?

745

FullIssueSummary September16

746

Full Audio Summary September16

747

Can't Touch This! Contamination of Laboratory Equipment with Bloodborne Pathogens

748

Discordance with 3 Cardiac Troponin I and T Assays: Implications for the 99th Percentile Cutoff

749

Ready, Set, Type! Proteomics vs Agglutination for Escherichia coli H Antigen Confirmation

750

The Promise-and Pitfalls-of Computerized Provider Alerts for Laboratory Test Ordering

751

Classifying Germline Sequence Variants in the Era of Next-Generation Sequencing

752

A 30-Year-Old Patient Who Refuses to Be Drug Tested

753

Full Audio Summary July16

754

Plasma Branched-Chain Amino Acids and Incident Cardiovascular Disease in the PREDIMED Trial

755

Incorporating Clinical Considerations into Statistical Analyses of Markers: A Quiet Revolution in How We Think About Data

756

Smartphones Can Monitor Medical Center Pneumatic Tube Systems

757

Postmarket Surveillance of Point-of-Care Glucose Meters through Analysis of Electronic Medical Records

758

Pharmacists in the Laboratory Space: Friends or Foes?

759

FullIssueSummary June2016

760

Different Susceptibility of B-Type Natriuretic Peptide (BNP) and BNP Precursor (proBNP) to Cleavage by Neprilysin: The N-Terminal Part Does Matter

761

Soluble CRTC3: A Newly Identified Protein Released by Adipose Tissue That Is Associated with Childhood Obesity

762

Effect of Dried Blood Spot Quality on Newborn Screening Analyte Concentrations and Recommendations for Minimum Acceptance Criteria for Sample Analysis

763

FullIssueSummary May2016

764

Nonfasting Sample for the Determination of Routine Lipid Profile: Is It an Idea Whose Time Has Come?

765

Mass Spectrometry–Based Adrenal and Peripheral Venous Steroid

766

Paper-Based Quantification of Male Fertility Potential

767

FullIssueSummary April2016

768

Clostridium difficile—Diagnostic and Clinical Challenges

769

Paper-Based Quantification of Male Fertility Potential

770

FullIssueSummary March2016

771

Impact of Implementing Preanalytical Laboratory Standards on the Diagnosis of Gestational Diabetes Mellitus: A Prospective Observational Study

772

Effect of Vitamin D or Activated Vitamin D on Circulating 1,25- Dihydroxyvitamin D Concentrations

773

Serum Total Testosterone Concentrations in the US Household Population from the NHANES 2011–2012 Study Population

774

FullIssueSummary February2016

775

Measurement by a Novel LC-MS/MS Methodology Reveals Similar Serum Concentrations of Vitamin D–Binding Protein in Blacks and Whites

776

US Food and Drug Administration Perspectives on Clinical Mass Spectrometry

777

Ambient Ionization Mass Spectrometry for Point-of-Care Diagnostics and Other Clinical Measurements

778

Clonotypic Light Chain Peptides Identified for Monitoring Minimal Residual Disease in Multiple Myeloma without Bone Marrow Aspiration

779

High-Resolution Mass Spectrometry for Characterizing the Metabolism of Synthetic Cannabinoid THJ-018 and Its 5-Fluoro Analog THJ-2201 after Incubation in Human Hepatocytes

780

Protein-Specific Glycoprofiling for Patient Diagnostics

781

Mass Spectrometry Selectivity, Specifically

782

FullIssueSummary January2016

783

Performance of Cystatin C– and Creatinine-Based Estimated Glomerular Filtration Rate Equations Depends on Patient Characteristics

784

"Big Data" in Laboratory Medicine

785

Optimizing Early Rule-Out Strategies for Acute Myocardial Infarction: Utility of 1-Hour Copeptin

786

Obese Nondiabetic Pregnancies and High Maternal Glycated Hemoglobin at Delivery as an Indicator of Offspring and Maternal Postpartum Risks:

787

STARD 2015: An updated list of essential items for reporting diagnostic accuracy studies

788

FullIssueSummary November2015

789

Extreme Nonfasting Remnant Cholesterol vs Extreme LDL Cholesterol as Contributors to Cardiovascular Disease and All-Cause Mortality in 90000 Individuals from the General Population

790

Nonfasting Lipid Profiles: The Way of the Future

791

Clopidogrel and CYP2C19: Pharmacogenetic Testing Ready for Clinical Prime Time?

792

Next-Generation Microfluidic Point-of-Care

793

FullIssueSummary October2015

794

Difference in Bias Approach for Commutability Assessment: Application to Frozen Pools of Human Serum Measured by 8 Direct Methods for HDL and LDL Cholesterol.

795

FullIssueSummary September2015

796

Pediatric Lipid Screening Rates in the US Are Low: What Can Labs Do to Help?

797

FullIssueSummary August2015

798

Why Disruptive Innovations Matter in Laboratory Diagnostics

799

Intersection of DNA Privacy and Whole-Genome Sequencing

800

FullIssueSummary July2015

801

24,25-Dihydroxyvitamin D3 and Vitamin D Status of Community-Dwelling Black and White Americans

802

Preanalytical Considerations in the Design of Clinical Trials and Epidemiological Studies

803

To Monitor Dabigatran or Not: A Matter of Patient Safety

804

Validation of New Cancer Biomarkers: A Position Statement from the European Group on Tumor Markers

805

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cutpoints—a joint consensus statement from the European Atherosclerosis Society and European Feder

806

FullIssueSummary June2015

807

Investigation of 2 Models to Set and Evaluate Quality Targets for Hb A1c: Biological Variation and Sigma-Metrics

808

FullIssueSummary May2015

809

Current Evidence and Future Perspectives on the Effective Practice of Patient-Centered Laboratory Medicine

810

Vitamin D: The More We Know, the Less We Know

811

FullIssueSummary April2015

812

Qualitative Point-of-Care Human Chorionic Gonadotropin Testing: Can We Defuse This Ticking Time Bomb?

813

Adaptive learning and medical education

814

Validation of a Proposed Novel Equation for Estimating LDL Cholesterol

815

Is This a Critical, Panic, Alarm, Urgent, or Markedly Abnormal Result?

816

Proposed Regulatory Framework for Direct-to-Consumer Genetic Testing: Diagnostics vs Genetic Screening

817

FullIssueSummary March2015

818

Learning from Our Mistakes: The Future of Validating Complex Diagnostics

819

Association of 1,5-Anhydroglucitol with Diabetes and Microvascular Conditions

820

Moving beyond mean glycemia: 1,5-anhydroglucitol and microvascular complications of diabetes

821

Noninvasive Prenatal Testing for Wilson Disease by Use of Circulating Single-Molecule Amplification and Resequencing Technology (cSMART)

822

The Landscape of MicroRNA, Piwi-Interacting RNA, and Circular RNA in Human Saliva

823

FullIssueSummary February2015

824

Clinical Exome Performance for Reporting Secondary

825

Next Generation Sequencing in Clinical Diagnostics: Experiences of Early

826

Chromosomal Instability in Cell-Free DNA Is a Serum Biomarker for Prostate Cancer

827

Refinement of Variant Selection for the LDL Cholesterol Genetic Risk Score in the Diagnosis of the Polygenic Form of Clinical Familial Hypercholesterolemia and Replication in Samples from 6 Countries

828

Extreme PCR: Efficient and Specific DNA Amplification in 15–60 Seconds

829

Total and Cause-Specific Mortality by Moderately and Markedly Increased Ferritin Concentrations: General Population Study and Metaanalysis

830

FullIssueSummary January2014

831

FullIssueSummary January2015

832

ClinChem 201411 Vaught

833

Integrative Bioinformatics Analysis Reveals New Prognostic Biomarkers of Clear Cell Renal Cell Carcinoma

834

Clinical Genomics: When Whole Genome Sequencing is like a Whole-body CT Scan

835

FullIssueSummary December2014

836

FullIssueSummary December2015

837

Emory: Experience with Ebola Patients

838

T2 Magnetic Resonance: A Diagnostic Platform for Studying Integrated Hemostasis in Whole Blood—Proof of Concept

839

Point/Counterpoint: The Quest for Clean Competition in Sports

840

Microfluidic Genotyping by Rapid Serial PCR and High-Speed Melting Analysis

841

FullIssueSummary November2014

842

Generation of a New Cystatin C–Based Estimating Equation for Glomerular Filtration Rate by Use of 7 Assays Standardized to the International Calibrator

843

Where Are All the New Omics-Based Tests?

844

Early Detection of Fragile X Syndrome: Applications of a Novel Approach for Improved Quantitative Methylation Analysis in Venous Blood and Newborn Blood Spots.

845

From Lost in Translation to Paradise Found: Enabling Protein Biomarker Method Transfer by Mass Spectrometry

846

FullIssueSummary October2014

847

Three of 7 Hemoglobin A1c Point-of-Care Instruments Do Not Meet Generally Accepted Analytical Performance Criteria

848

Influence of the Confounding Factors Age and Sex on MicroRNA Profiles from Peripheral Blood

849

Maternal Plasma RNA Sequencing for Genome-Wide Transcriptomic Profiling and Identification of Pregnancy-Associated Transcripts

850

Podcasts Go Platinum!

851

Measurements for 8 Common Analytes in Native Sera Identify Inadequate Standardization among 6 Routine Laboratory Assays

852

FullIssueSummary September2014

853

Immunoextraction - tandem mass spectrometry method for measuring intact human chorionic gonadotropin, free beta, and beta core fragment in urine

854

To P or not to P: that is the question

855

Weekly and 90-Minute Biological Variations in Cardiac Troponin T and Cardiac Troponin I in Hemodialysis Patients and Healthy Controls

856

FullIssueSummary August2014

857

Biomarkers of Brain Injury in Cerebral Infections

858

Novel Biomarkers for Acute Myocardial Infarction: Is MicroRNA the New Kid on the Block?

859

ClinChem 201406 deLemos Khalili

860

FullIssueSummary July2014

861

Harmonization of Test Results: What Are the Challenges; How Can We Make It Better?

862

The FDA and 23andMe: Violating the First Amendment or Protecting the Rights of Consumers?

863

When a “Disease-Causing Mutation” Is Not a Pathogenic Variant

864

Genetically Low Triglycerides and Mortality: Further Support for “the Earlier the Better”?

865

FullIssueSummary June2014

866

Low Nonfasting Triglycerides and Reduced All-Cause Mortality: A

867

Interlaboratory Agreement of Insulin-like Growth Factor 1 Concentrations Measured by Mass Spectrometry

868

Interferon γ–Release Assays for Diagnosis of Latent Tuberculosis in Healthcare Workers in Low-Incidence Settings: Pros and Cons

869

Development of an Immunoassay for the Kidney-Specific Protein myo-

870

Posttransplantation Bone Marrow Assessment by Quantifying Hematopoietic Cell–Derived mRNAs in Plasma Exosomes/Microvesicles

871

Sandwich Assay for Tacrolimus Using 2 Antitacrolimus Antibodies

872

Novel Uses for Platelet Function Testing in the Clinical Laboratory: Where Are We Now?

873

Publication and Reporting of Test Accuracy Studies Registered in ClinicalTrials.gov

874

Screening Method to Evaluate Point-of-Care Human Chorionic Gonadotropin (hCG) Devices for Susceptibility to the Hook Effect by hCG β Core Fragment: Evaluation of 11 Devices

875

Influence of PCR Reagents on DNA Polymerase Extension Rates Measured on Real-Time PCR Instruments

876

FullIssueSummary April2014

877

Islet autoantibodies and type 1 diabetes: does the evidence support screening?

878

Digital PCR as a Novel Technology and Its Potential Implications for Molecular Diagnostics

879

Diagnosis of Gestational Diabetes Mellitus: it is time for international consensus

880

Invention and Validation of an Automated Camera System That Uses Optical Character Recognition to Identify Patient Name Mislabeled Specimens

881

FullIssueSummary March2014

882

FullIssueSummary May2014

883

Diagnosis of Gestational Diabetes Mellitus: It Is Time for International Consensus.

884

Biomarkers for Acute Kidney Injury: Where Are We Today? Where Should We Go?

885

Genomic Test Validation for Incidental Findings

886

As if Biomarker Discovery wasn’t Hard Enough

887

FullIssueSummary February2014

888

High-Sensitivity Cardiac Troponin Assays: Isn't It Time for Equality?

889

Tumor Microenvironment–Released Peptides: Could They Form the Basis for an Early-Diagnosis Breast Cancer Test?

890

What’s Different about Women’s Health?

891

The Ethical Implications of Preimplantation Genetic Diagnosis

892

Gestational Diabetes Mellitus

893

Diagnosing Diabetes Mellitus: Performance of Hemoglobin A1c Point-of-Care Instruments in General Practice Offices

894

FullIssueSummary December2013

895

Digital Droplet PCR for Rapid Quantification of Donor DNA in the Circulation of Transplant Recipients as a Potential Universal Biomarker of Graft Injury

896

Multiplex Picodroplet Digital PCR to Detect KRAS

897

MicroRNA Signature Helps Distinguish Early from Late Biochemical Failure in Prostate Cancer

898

FullIssueSummary November2013

899

Bioinformatics: What the Clinical Laboratorian Needs to Know and Prepare For

900

Use of MALDI-TOF for diagnosis of microbial infections

901

ClinChem 201310 Rifai

902

False Biomarker Discovery Due to Reactivity of a Commercial ELISA for CUZD1 with Cancer Antigen CA125

903

FullIssueSummary October2013

904

Scanning for cancer genomic changes in plasma: towards an era of personalized blood-based tumor markers

905

Automation in the Clinical Microbiology Laboratory

906

Automation in the Clinical Microbiology Laboratory

907

Point-of-Care and Over-the-Counter Qualitative Human Chorionic Gonadotropin (hCG) Devices Remain Susceptible to False-Negative Results Caused by Excess hCG β Core Fragment

908

Twenty-Eight Grams of Prevention Is Worth a Half Kilogram of Cure

909

FullIssueSummary September2013

910

A New Era in Prenatal Diagnosis: The Use of Cell-Free Fetal DNA in Maternal Circulation for Detection of Chromosomal Aneuploidies

911

Failure of Current Laboratory Protocols to Detect Lot-to-Lot Reagent Differences: Findings and Possible Solutions

912

ClinChem 201308 Korf

913

FullIssueSummary August2013

914

FDA Oversight of Laboratory-Developed Tests: Is It Necessary, and How Would It Impact Clinical Laboratories?

915

FDA Oversight of Laboratory-Developed Tests: Is It Necessary, and How Would It Impact Clinical Laboratories?

916

FDA Oversight of Laboratory-Developed Tests: Is It Necessary, and How Would It Impact Clinical Laboratories?

917

Noninvasive Prenatal Methylomic Analysis by Genomewide Bisulfite Sequencing of Maternal Plasma DNA

918

Gaps in the Traceability Chain of Human Growth Hormone Measurements

919

Newborn Screening by Sequence and the Road Ahead

920

Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid-β1–42 and τ Proteins as Alzheimer Disease Biomarkers

921

FullIssueSummary July2013

922

Measurement of Thyroglobulin by Liquid Chromatography–Tandem Mass Spectrometry in Serum and Plasma in the Presence of Antithyroglobulin Autoantibodies

923

Cobalt and Chromium Measurement in Patients with Metal Hip Prostheses

924

Beyond LDL-C in assessing cardiovascular risk: ApoB or LDL-P?

925

FullIssueSummary June2013

926

Are Biomarkers the Answer to the Heart Failure Readmissions Problem?

927

Vitamin D and Cancer: Can We Believe the Evidence from Observational Studies?

928

Circulating MicroRNAs: What Is Their Relevance?

929

Molecular detection of human H7N9 influenza A virus causing outbreaks in China

930

Targeting the Circulating MicroRNA Signature of Obesity

931

FullIssueSummary May2013

932

The Economic Potential of Pharmacogenomics

933

The Human Gut Microbiome and Body Metabolism: Implications for Obesity and Diabetes

934

Q&A on Pheochromocytoma

935

Mobile device for disease diagnosis and data tracking in resource-limited settings

936

MicroRNAs in Idiopathic Childhood Nephrotic Syndrome

937

Predicting the Cost and Pace of Pharmacogenomic Advances: An Evidence-Based Study

938

Communication of Scientific Information: Is It Time to Reassess?

939

FullIssueSummary April2013

940

Male Infertility and Microchips

941

Cannabis Effects on Driving Skills

942

ClinChem 201305 Nordestgaard

943

More Data, Please!

944

MALDI-TOF Mass Spectrometry: Transformative Proteomics for Clinical Microbiology

945

FullIssueSummary March2013

946

Is Early Detection of Cancer with Circulating Biomarkers Feasible?

947

External Quality Assessment of Point-of-Care Methods: Model For Combined Assessment of Method Bias and Single-Participant Performance by the Use of Native Patient Samples and Noncommutable Control Material

948

MicroRNA Analysis: Is It Ready for Prime Time?

949

Commercial Immunoassays in Biomarkers Studies: Researchers Beware!

950

Data Submission and Quality in Microarray-Based MicroRNA Profiling

951

Comparing Multiple Measures of Glycemia: How to Transition from Biomarker to Diagnostic Test?

952

FullIssueSummary Feb2013

953

The Riddle of Protein Diagnostics: Future Bleak or Bright?

954

Conquering Cancer in Our Lifetime: New Diagnostic and Therapuetic Trends

955

Plasma-derived Tumor DNA analysis at whole genome resolution;

956

Validating Serum Markers for Monitoring of Cancer

957

Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing

958

Design of Tumor Biomarker-Monitoring Trials: A Proposal by the European Group on Tumor Markers

959

FullIssueSummary Jan2013

960

Associations of Alternative Markers of Glycemia with Hemoglobin A1c and Fasting Glucose

961

Quantitative PCR Analysis of DNA, RNAs, and Proteins in the Same Single Cell

962

The Evolving Threat of Influenza Viruses of Animal Origin and the Challenges in Developing Appropriate Diagnostics;

963

Performance Criteria for Testosterone Measurements Based on Biological Variation in Adult Males: Recommendations from the Partnership for the Accurate Testing of Hormones

964

Medicine Unplugged: The Future of Laboratory Medicine

965

Medicine Unplugged: The Future of Laboratory Medicine

966

Longitudinal Studies of Cardiac Troponin I in a Large Cohort of Healthy Children

967

FullIssueSummary Dec2012

968

Determination of 19 Cardiac Troponin I and T Assay 99th Percentile Values from a Common Presumably Healthy Population

969

On-Site Test for Cannabinoids in Oral Fluid

970

ClinChem FullIssueSummary Nov2012

971

Ectopic Pregnancy

972

Exome and Whole-Genome Sequencing as Clinical Tests: A Transformative Practice in Molecular Diagnostics

973

More Reliable On-Site Detection of Cannabis in Oral Fluid

974

Room for Improvement in National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines

975

Applicability of the AGREE II Instrument in Evaluating the Development Process and Quality of Current National Academy of Clinical Biochemistry Guidelines

976

The Human Salivary RNA Transcriptome Revealed by Massively Parallel Sequencing

977

Noninvasive Prenatal Diagnosis of Monogenic Diseases by Targeted Massively Parallel Sequencing of Maternal Plasma: Application to β-Thalassemia

978

Whole-Blood Thrombin Generation Monitored with a Calibrated Automated Thrombogram-Based Assay

979

Caution Is Needed in the Interpretation of Added Value of Biomarkers Analyzed in Matched Case Control Studies

980

Interpreting Cardiac Troponin Results from High-Sensitivity Assays in Chronic Kidney Disease without Acute Coronary Syndrome

981

Thyroid Function during Pregnancy: Who and How Should We Screen?

982

Circulating Human Hepcidin-25 Concentrations Display a Diurnal Rhythm, Increase with Prolonged Fasting, and Are Reduced by Growth Hormone Administration

983

Antibiotic Resistance: How Serious Is the Problem, and What Can Be Done?

984

A Unique Approach to Business Strategy as a Means to Enable Change in Global Healthcare: A Case Study

985

Establishing Pediatric Reference Intervals: A Challenging Task

986

Newer Fecal Tests: Opportunities for Professionals in Laboratory Medicine

987

Diagnostic Accuracy of Point-of-Care Fecal Calprotectin and Immunochemical Occult Blood Tests for Diagnosis of Organic Bowel Disease in Primary Care: The Cost-Effectiveness of a Decision Rule for Abdominal Complaints in Primary Care (CEDAR) Study

988

The Obesity Epidemic

989

Altering the Landscape for Women in Clinical Chemistry: Perspectives from Multigenerational Leaders

990

Elementary, My Dear Doctor Watson

991

Clinician's Perspective: Allan Jaffe

992

Patents and Laboratory Medicine: What Is Required to Turn an Unpatenable Natural Phenomenon or Law of Nature into a Patenable Invention?

993

Closing the Gaps in Pediatric Laboratory Reference Intervals: A CALIPER Database of 40 Biochemical Markers in a Healthy and Multiethnic Population of Children

994

Inappropriate Requesting of Glycated Hemoglobin (Hb A1c) Is Widespread: Assessment of Prevalence, Impact of National Guidance, and Practice-to-Practice Variability

995

Genetic Susceptibility for Coronary Heart Disease and Type 2 Diabetes Complications

996

Catch Me If You Can: Isolating Circulating Tumor Cells from Flowing Blood

997

Refining Noninvasive Prenatal Diagnosis with Single-Molecule Next-Generation Sequencing

998

Understanding the Mechanisms That Link Alcohol and Lower Risk of Coronary Heart Disease

999

Microtube Device for Selectin-Mediated Capture of Viable Circulating Tumor Cells from Blood

1000

Fluorescence Sensor for the Quantification of Unbound Bilirubin Concentrations